- Todos > Medicine Access and Rational Use > Supply Management
- Todos > Quality and Safety: Medicines > Quality Assurance
- Palabras clave > antimalarial medicines (AMLs)
- Palabras clave > antimalarials – supply and distribution
- Palabras clave > artemisinin resistance
- Palabras clave > National Medicines Regulatory Authority (NMRA)
- Palabras clave > pharmaceutical supply chain
- Palabras clave > post marketing surveillance
- Palabras clave > President's Malaria Initiative (PMI)
- Palabras clave > quality assurance - medicines
- Palabras clave > regulatory assessment
- Palabras clave > supply chain management
(2017; 48 pages)
Despite the considerable progress in malaria control across the Greater Mekong Subregion (GMS), malaria remains a significant public health concern, with growing resistance to antimalarial drugs threatening to undermine recent gains. The GMS countries of Cambodia, the Lao People’s Democratic Republic, Myanmar, Thailand and Viet Nam will continue to require appropriate interventions for prevention, diagnosis and treatment. Effective procurement and supply chain management systems are crucial to ensure the timely availability of commodities to address malaria prevention and treatment.
Across GMS, procurement and supply chain systems have evolved into complex mechanisms and processes that involve various stakeholders. These developments reflect significant efforts by countries to expand vector-control interventions, as well as efforts to improve the quality and availability of diagnosis and treatment, including focus on community-based services and improved integration with the private sector. Additionally, due to the continued presence of donor funding – in particular the Global Fund to Fight AIDS, Tuberculosis and Malaria – many external partners work directly in the procurement and supply chain process, alongside domestic agencies and organizations.
While all countries have developed systems that aim to procure quality-assured commodities and distribute them throughout the health system and on to patients, there are ongoing challenges with workforce capacity, storage conditions, delivery, quality assurance, and the collection and use of timely data. Additionally, the decreasing number of malaria cases across the subregion calls for efforts to sustain funding, resources and engagement.
GMS countries can continue to improve their supply chains through increased communication and collaboration among key stakeholders, greater clarity of roles and responsibilities, formalization of procedures and processes, and wider availability of data to support decision-making.